[1] Maban E. Cardiac channelopathies[J].Nature,2002,415(6868):213-218.
[2] Ack erman MJ. Cardi ac channelopathies:It's in the genes.[J].Nat Med,2004,10(5):463-464.
[3] 李翠兰,胡大一.离子通道病的种类和特点[J].中国民康医学杂志,2005,17(2):76-80.
[4] Priori SG,Bahanin J Hauer RN,et al. Genetic and molecular basis of Cardiac arhythmias:Impact on clinical management (Parts 1 and I)[J]. Circulation,1999,99(4):518-528.
[5] Zhang L,Timothy KW,Vincent GM,et al. Spectrum of ST:T-w ave patterns and repolan zat lon parameters in congeni tal long QT syndrome:FCG findings identify genotypes[J].Circulation,2000,102(23):2849-2855.
[6] Splawski I,Timothy KW,Sharpe IM,et al. Ca(V)1.2 calcium channel dysfundf ion causes a mult isystem di sorder including arhythmia and autism[J].Cel 2004,119(1):19-31.
[7] Weiss R,Barmada MM,Nguyen T,et al.Clinical and molecular heterogeneity in the Brugada syndrome:a novel gene locus on ch romosome 3[J]. Circulation,2002,105(6):707-713.
[8] Max SO,Reilen S,Hisamatsu Y,et al. PKA phosphory lation dissociates FKBP12. 6 from the calcium release channel (ryanodi ne receptor ):Defective regulation in failing heart[J]. Cel,2000,101(4):365-376.
[9] Viatchenko Kapinski S,Terentyev D,Gyorke I,et al. Ab-nomal calcium signaling and sudden cardiac death associated with mutation of ealsequestrin[J].Cire Res 2004 94(4):471.
[10] Bellocq C,van Ginneken AC,Bezzina CR et al. Mutation in the KCNQ1 gene leading to the short QTinterval syndrome[J]. Circulation,2004 109(20):2394.
[11] Prioni SG,Pandit SV,RivoltaI,et al. A novel norm of short QT syndrome(SQT3) is caused by a mutation in the KC NJ2 gene[J]. Circ Res2005,96(7):800.
[12] Watanbe T,Yarnaki M,Yamauchi S,et al. Am J Physiol,2002,282(1):H212-H218.
[13] 王德国,柯永胜,汪和贵,等.内洋地黄素拮抗剂减轻心肌缺血再灌注损伤的实验研究[J].中华急诊医学杂志,2004,13(3):165-168.
[14] 汪和贵,王德国,柯永胜,等.地高辛抗血清拮抗内源性洋地黄样物质介导的离体大鼠心脏再灌注心律失常的实验研究[J].中华心律失常学杂志,2004,8(5):285-289.
[15] 李翠兰胡大一.长QT综合征的最新研究进展[J].心脏杂志,2004,16(1):76-79.
[16] 刘文玲,胡大一.遗传性心脏猝死综合征2005AHA新观点及新进展[J].中国心脏起搏与心电生理杂志,2006 20(1):16-17.
[17] 姚艳,浦介麟.遗传性室性心律失常的药物防治[J].中国心脏起搏与心电生理杂志,2007,21(4):285-287.
[18] ACC/ AHA/ ESC 2006 Guidelines for Management of patients with ventricular arhythmias and the prevention of sudden cardiac death[J].Circulation,2006 114(10):385.
[19] 杨新春,李延辉.遗传性心律失常综合征[J].临床内科杂志,2006 23(7):443-446.
[20] Hemmida.S,Denjoy I,Clerc J,et al. Hydroquinidine therapy in Brugada syndome[J].Am Coil Cardiol,2004,43(10):1853.
[21] 洪葵.遗传性室性心律失常[J].临床心电学杂志2006,15(4):243-250.
[22] Wehens XH,Lehnart SE,Reiken SR,et al.Protection from cardiac Anrhythmia through ryanodinereceptor-stabilizing protein calstabin2[J]. Science,2004,304(5668):292.
[23] Lehnart SE,Wehrens XH,Laitinen PJ,et al. Sudden death in fami lial polymophic vent ri cul ar tachycardia associated with calcium rel ease channel(ry anodine receptor)leak[J].Ci rculation,2004,109(25):3208.
[24] Sumitomo N,Harada K,Nagashima M,et al. Cat echolaminengic polymorphic ventricular tachy cardia:Eledt rocardiogaphic charac erist icsand optimal therapeutic st rategies to prevent sudden death[J]. Heart 2003,89(1):66.
[25] 郭成军,张英川方冬平,等.导管消融治疗短QT综合征患者多频率室性心动过速和心室颤动一例[J].中华心血管病杂志,2005,33(1):90-91.
[26] 罗静,杨新春,王乐丰,等.奎尼丁对吡那地尔诱导的犬右心室跨壁复极离散的影响J].中华心血管病杂志,2005,33(4):369-371.
[27] 黄浙勇,葛均波.干细胞移植治疗心律失常的研究进展[J].中国临床医学,2007,14(2):151-154.
[28] 马克娟,浦介麟.遗传性心律失常基因研究近况[J].中国心脏起搏与心电生理杂志2006,20(1):4-7. |
